Engineering protein for X-ray crystallography: The murine major histocompatibility complex class II molecule I-A(d)

Protein Science

Volumn 7, Issue 2, 1998, Pages 413-418

  Scott, Christopher A ^a   Christopher Garcia, K ^a   Stura, Enrico A ^a   Peterson, Per A ^b   Wilson, Ian A ^a   Teyton, Luc ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Drosophila melanogaster protein expression; His tagged protein; Preparative IEF; Protein deglycosylation; Surface plasmon resonance; Thrombin digestion; X ray crystallography

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THROMBIN;

ARTICLE; DROSOPHILA MELANOGASTER; GENETIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; T LYMPHOCYTE; X RAY CRYSTALLOGRAPHY;

EID: 2642652229     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070222     Document Type: Article

References (40)

1. Bikoff EK, Huang LY, Episkopou V, van Meerwijk J, Germain RN, Robertson EJ. 1993. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med 177:1699-1712.
2. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. 1987. Structure of the human class I histocompalibility antigen, HLA-A2. Nature 329:506-512.
3. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39.
4. Carbone FR, Bevan MJ. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med 169:603-612.
5. Chiocchia G, Manoury B, Boissier MC, Fournier C. 1993. T cell-targeted immunotherapy in murine collagen-induced arthritis. Clin Exp Rheumatol 11:S15-S17.
6. Cresswell P. 1994. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259-293.
7. b. Science 257:919-927.
8. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA 92:2479-2483.
9. Fremont DH, Hendrickson WA, Marrack P, Kappler J. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001-1004.
10. Germain RN. 1994. MHC-dependent antigen processing and peptide presentation: Providing ligands for T-lymphocyte activation. Cell 76:287-299.
11. Germain RN, Hendrix LR. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134-139.
12. Ghosh P, Amaya M, Mellins E, Wiley DC. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457-462.
13. Howard AJ, Gilliland GL, Finzel BC, Poulus TL, Ohlendorf DH, Salemme FR. 1987. The use of an imaging proportional counter in macromolecular crystallography. J Appl Crystallogr 20:383-387.
14. Jackson MR, Song ES, Yang Y, Peterson PA. 1992. Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. Proc Natl Acad Sci USA 89:12117-12121.
15. Jancarik J, Kim SH. 1991. Sparse matrix sampling: A screening method for crystallization of proteins. J Appl Crystallogr 24:409-411.
16. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711-718.
17. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. 1996. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci USA 93:734-738.
18. Kappler J, Scidmore B, Marrack P. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 153:1198-1214.
19. Korman AJ, Boss JM, Spies T, Sorrentino R, Okada K, Strominger JL. 1985. Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev 85:45-86.
20. Kozono H, White J, Clements J, Marrack P, Kappler J. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151-154.
21. Lafuse WP. 1991. Molecular biology of murine MHC class II genes. Crit Rev Immunol 11:167-194.
22. Lee JM, Watts TH. 1990. On the dissociation and reassociation of MHC class II-foreign peptide complexes. Evidence that brief transit through an acidic compartment is not sufficient for binding site regeneration. J Immunol 144:1829-1834.
23. Martin R, McFarland HF, McFarlin DE. 1992. Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187.
24. Matsumura M, Fremont DH, Peterson PA, Wilson IA. 1992a. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927-934.
25. Matsumura M, Saito Y, Jackson MR, Song ES, Peterson PA. 1992b. In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. J Biol Chem 267:23589-23595.
26. Mengle-Gaw L, McDevitt HO. 1985. Genetics and expression of mouse Ia antigens. Annu Rev Immunol 3:367-396.
27. Nag B, Arimilli S, Koukis B, Rhodes E, Baichwal V, Sharma SD. 1994. Intramolecular charge heterogeneity in purified major histocompatibility class II alpha and beta polypeptide chains. J Biol Chem 269:10061-10070.
28. Rammensee HG, Friede T, Stevanoviic S. 1995. MHC ligands and peptide motifs: First listing. Immunogenetics 41:178-228.
29. Sadegh-Nasseri S, Germain RN. 1991. A role for peptide in determining MHC class II structure. Nature 353:167-170.
30. Saper MA, Bjorkman PJ, Wiley DC. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 219:277-319.
31. Scott CA, Garcia KC, Carbone FR, Wilson IA, Teyton L. 1996. Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J Exp Med 183:2087-2095.
32. Sheldrick GM. 1994. XPREP - Data preparation and reciprocal space evaluation. Goettingen, Germany: Siemens Analytical X-ray Instruments.
33. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221.
34. Stern LJ, Wiley DC. 1994. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2:245-251.
35. Stura EA, Wilson IA. 1992. Seeding techniques. In: Ducruix A, Giege R, eds. Crystallization of nucleic acids and proteins. Oxford, UK: Oxford University Press. pp 99-126.
36. Stura EA, Nemerow GR, Wilson IA. 1992. Strategies in the crystallization of glycoproteins and protein complexes. J Cryst Growth 122:273-285.
37. Stura EA, Satterthwait AC, Calvo JC, Kaslow DC, Wilson IA. 1994. Reverse screening. Acta Crystallogr D50:448-455.
38. Wicker LS, Todd JA, Peterson LB. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200.
39. Wilson IA. 1994. Covalently-linked ligand stabilizes expression of heterodimeric receptor. Structure 2:561-562.
40. Wilson IA. 1996. Another twist to MHC-peptide recognition. Science 272:973-974.